Powerful cholesterol drug cuts heart attack risk by 31%
Mass General Brigham researchers report that the cholesterol-lowering drug evolocumab can significantly reduce the risk of a first major cardiovascular event in people with diabetes who are considered high risk but do not yet have diagnosed atherosclerosis (the build-up of plaque inside artery walls). The findings were presented at the…
